The primary objective of the research is to study the relation between the presence and/or the anti SARS-Co-V-2 IgM level in an early stage of COVID-19 infection, and theevolution of the illness.
The secondary objective is to determinate in what manner response of IgM anti-SARS-Co-V-2
relates to patient's immunity statute, in regards to the other so-called humain "seasonal
coronavirus".
Inclusion Criteria:
- Patients ≥ 18 years;
- Have been diagnosed positive of SARS-CoV-2 in the Virological Laboratory of Ambroise
Paré hospital;
- Have been blood sampled between 1 day and 14 days from the first clinical syndromes,
and their collections of serum or plasma are conserved and accessible;
- Affiliated to the social security scheme or entitled;
- Informed and non-opposed to participating to the study.
Exclusion Criteria:
- Opposition of patient to participation to the study;
- Foreign patients under french AME scheme.
Not Provided
Jean-Louis Gaillard, MD, PhD
+ 33 (0)1 49 09 55 40
jean-louis.gaillard@aphp.fr
Jean-Louis Gaillard, MD, PhD, Principal Investigator
Microbiological Laboratory - CHU Ambroise Paré - APHP